As of December 31, 2024, the fair values of our financial assets and liabilities were categorized as follows:


	Total		Level 1		Level 2		Level 3
Assets
Investment in equity securities (1)	$	2,986	$	2,986	$	—	$	—
Foreign exchange contracts (2)	572		—		572		—

Convertible notes (3)	5,650		—		—		5,650
Total assets at fair value	$	9,208	$	2,986	$	572	$	5,650
Liabilities
Foreign exchange contracts (2)	$	622	$	—	$	622	$	—
Cross currency swap contract (2)	11,851		—		11,851		—

Total liabilities at fair value	$	12,473	$	—	$	12,473	$	—

As of December 31, 2023, the fair values of our financial assets and liabilities were categorized as follows:


	Total		Level 1		Level 2		Level 3
Assets
Investment in equity securities (1)	$	1,106	$	1,106	$	—	$	—
Foreign exchange contracts (2)	386		—		386		—

Convertible notes (3)	5,650		—		—		5,650
Total assets at fair value	$	7,142	$	1,106	$	386	$	5,650
Liabilities
Foreign exchange contracts (2)	$	221	$	—	$	221	$	—
Cross currency swap contract (2)	22,199		—		22,199		—

Total liabilities at fair value	$	22,420	$	—	$	22,420	$	—

(1)Investment in PureCycle Technologies ("PCT" or "PureCycle"). See Note 20 - Investment in Equity Securities for discussion of this investment.

(2)Market approach valuation technique based on observable market transactions of spot and forward rates.

(3)Investment in convertible notes in Enable Injections, Inc. and Siklus Refill Pte, Ltd. The investments are included within Miscellaneous assets in our Consolidated Balance Sheets.